BioSpace News Archive

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced updates related to the company’s commitment to the amyotrophic lateral sclerosis (ALS) community, in celebration of the third anniversary of the U.S. availability of RADICAVA ® (edaravone).

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, announced today that Cleveland Clinic has joined GRAIL’s PATHFINDER Study, a prospective, multi-center clinical study that is evaluating the implementation of Galleri™, an investigational multi-cancer early detection blood test, into clinical practice for the first time.

Yulong Eco-Materials Limited announced that it has changed its name to EV Biologics, Inc.

Adial Pharmaceuticals, Inc. today announced that it has entered into an agreement with Brik LLC , an independent sales and marketing firm, to act as a third-party agent to Adial for the sale and distribution of Rapid Result COVID-19 antibody test kits.

Esteemed molecular pathologist to accelerate the use of real-world data for life sciences and health systems product and service development

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation, announced today the appointment of veteran medical device executive J. Brent Ratz to the role of Chief Executive Officer of the company and executive member of the Board of Directors.

Nanotronics today announced the formation of Nanotronics Health, LLC, a healthcare technology company whose mission is to create urgently needed medical devices that are accessible, affordable, easy to use, and intelligently designed.

PRIMED Medical Products (PRIMED) has today announced its intent to establish a new major medical manufacturing facility in Canada.

joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce that Intracs®em, its electromagnetic navigation tracking and control system, has been approved by the FDA.

Neura, the leader in AI-powered behavioral intelligence providing real-world insights for health organizations, governments, and consumer brands today announced the adoption of ViruScore™ COVID-19 predictive testing solution.